SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001280600-21-000004
Filing Date
2021-02-04
Accepted
2021-02-04 07:21:13
Documents
14
Period of Report
2021-02-04
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K xlrn-20210204.htm   iXBRL 8-K 39987
  Complete submission text file 0001280600-21-000004.txt   181460

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xlrn-20210204.xsd EX-101.SCH 2457
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xlrn-20210204_cal.xml EX-101.CAL 736
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xlrn-20210204_def.xml EX-101.DEF 1673
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xlrn-20210204_lab.xml EX-101.LAB 24275
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xlrn-20210204_pre.xml EX-101.PRE 12672
7 EXTRACTED XBRL INSTANCE DOCUMENT xlrn-20210204_htm.xml XML 10757
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36065 | Film No.: 21588856
SIC: 2836 Biological Products, (No Diagnostic Substances)